GenMont Biotech Inc (3164) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, GenMont Biotech Inc (3164) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-4.77 Million ≈ $-150.19K USD) by net assets (NT$1.39 Billion ≈ $43.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

GenMont Biotech Inc - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how GenMont Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GenMont Biotech Inc (3164) financial obligations for a breakdown of total debt and financial obligations.

GenMont Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GenMont Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
IT City Public Company Limited BK:IT	0.085x
Findi Ltd AU:FND	-0.237x
SRG HOUSING FINANCE ORD (BSE) NSE:SRGHFL	-0.337x
Korea Refract KO:010040	-0.125x
Energia Latina SA SN:ENLASA	0.077x
NOMADAR Corp. Class A Common Stock NASDAQ:NOMA	-0.287x
IBKS No. 15 Special Purpose Acquisition Co. Ltd. KQ:373200	-0.554x
Ewein Bhd KLSE:7249	-0.006x

Annual Cash Flow Conversion Efficiency for GenMont Biotech Inc (2005–2024)

The table below shows the annual cash flow conversion efficiency of GenMont Biotech Inc from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of GenMont Biotech Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.48 Billion ≈ $46.62 Million	NT$123.95 Million ≈ $3.90 Million	0.084x	+250.84%
2023-12-31	NT$1.45 Billion ≈ $45.66 Million	NT$34.60 Million ≈ $1.09 Million	0.024x	-74.09%
2022-12-31	NT$1.50 Billion ≈ $47.17 Million	NT$137.95 Million ≈ $4.35 Million	0.092x	+25.79%
2021-12-31	NT$1.52 Billion ≈ $48.03 Million	NT$111.66 Million ≈ $3.52 Million	0.073x	-8.23%
2020-12-31	NT$1.48 Billion ≈ $46.69 Million	NT$118.27 Million ≈ $3.73 Million	0.080x	+55.11%
2019-12-31	NT$1.45 Billion ≈ $45.62 Million	NT$74.52 Million ≈ $2.35 Million	0.051x	+43.51%
2018-12-31	NT$1.56 Billion ≈ $49.23 Million	NT$56.03 Million ≈ $1.77 Million	0.036x	-36.63%
2017-12-31	NT$1.37 Billion ≈ $43.19 Million	NT$77.56 Million ≈ $2.44 Million	0.057x	+59.70%
2016-12-31	NT$1.28 Billion ≈ $40.32 Million	NT$45.34 Million ≈ $1.43 Million	0.035x	+1161.02%
2015-12-31	NT$1.50 Billion ≈ $47.27 Million	NT$-5.01 Million ≈ $-157.84K	-0.003x	+91.40%
2014-12-31	NT$1.60 Billion ≈ $50.32 Million	NT$-62.00 Million ≈ $-1.95 Million	-0.039x	-132.38%
2013-12-31	NT$837.28 Million ≈ $26.38 Million	NT$100.37 Million ≈ $3.16 Million	0.120x	+538.11%
2012-12-31	NT$861.62 Million ≈ $27.15 Million	NT$-23.58 Million ≈ $-742.77K	-0.027x	-161.99%
2011-12-31	NT$904.75 Million ≈ $28.50 Million	NT$39.94 Million ≈ $1.26 Million	0.044x	-83.72%
2010-12-31	NT$737.87 Million ≈ $23.25 Million	NT$200.03 Million ≈ $6.30 Million	0.271x	+58.78%
2009-12-31	NT$635.68 Million ≈ $20.03 Million	NT$108.53 Million ≈ $3.42 Million	0.171x	+3.44%
2008-12-31	NT$609.60 Million ≈ $19.21 Million	NT$100.62 Million ≈ $3.17 Million	0.165x	+99.72%
2007-12-31	NT$524.64 Million ≈ $16.53 Million	NT$43.36 Million ≈ $1.37 Million	0.083x	+29.07%
2006-12-31	NT$461.75 Million ≈ $14.55 Million	NT$29.56 Million ≈ $931.43K	0.064x	+94.99%
2005-12-31	NT$290.14 Million ≈ $9.14 Million	NT$9.53 Million ≈ $300.15K	0.033x	--

About GenMont Biotech Inc

TW:3164 Taiwan Biotechnology

Market Cap

$47.96 Million

NT$1.52 Billion TWD

Market Cap Rank

#22045 Global

#1362 in Taiwan

Share Price

NT$17.70

Change (1 day)

-0.28%

52-Week Range

NT$17.55 - NT$21.35

All Time High

NT$30.54